Status report: Medication without harm WHO Global Patient Safety Challenge Australia’s response (June 2024)

Summary

This status report by the Australian Commission on Safety and Quality in Healthcare looks at achievements against the recommendations in 'Medication without harm – WHO Global Patient Safety Challenge: Australia’s response'. The report examines data published to the end of June 2023 and published papers to the end of February 2024. It examines the impact of programs implemented to address the priority actions identified in the three WHO flagship areas:

1. Monitoring polypharmacy and responding to inappropriate polypharmacy
2. Reducing harm from high-risk medicines, with focus on insulin, opioid analgesics, anticoagulants and antipsychotics
3. Improving medication safety at transitions of care.